257 related articles for article (PubMed ID: 25377223)
1. A hypoxia-responsive glial cell-specific gene therapy vector for targeting retinal neovascularization.
Biswal MR; Prentice HM; Dorey CK; Blanks JC
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8044-53. PubMed ID: 25377223
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-regulated retinal glial cell-specific promoter for potential gene therapy in disease.
Prentice HM; Biswal MR; Dorey CK; Blanks JC
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8562-70. PubMed ID: 21960554
[TBL] [Abstract][Full Text] [Related]
3. Targeting endostatin to potentially prevent retinal neovascularization using a hypoxia-responsive Müller glia cell-specific gene therapy.
Craft CM
Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8054. PubMed ID: 25504477
[No Abstract] [Full Text] [Related]
4. Helper-dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy.
Lamartina S; Cimino M; Roscilli G; Dammassa E; Lazzaro D; Rota R; Ciliberto G; Toniatti C
J Gene Med; 2007 Oct; 9(10):862-74. PubMed ID: 17685494
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy.
Fu ZJ; Li SY; Kociok N; Wong D; Chung SK; Lo AC
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5698-712. PubMed ID: 22836764
[TBL] [Abstract][Full Text] [Related]
6. Ebselen by modulating oxidative stress improves hypoxia-induced macroglial Müller cell and vascular injury in the retina.
Tan SM; Deliyanti D; Figgett WA; Talia DM; de Haan JB; Wilkinson-Berka JL
Exp Eye Res; 2015 Jul; 136():1-8. PubMed ID: 25912997
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.
Saito Y; Geisen P; Uppal A; Hartnett ME
Mol Vis; 2007 Jun; 13():840-53. PubMed ID: 17615545
[TBL] [Abstract][Full Text] [Related]
8. Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularization.
Biswal MR; Prentice HM; Smith GW; Zhu P; Tong Y; Dorey CK; Lewin AS; Blanks JC
J Mol Med (Berl); 2018 Oct; 96(10):1107-1118. PubMed ID: 30105447
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
10. Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR).
Scott A; Powner MB; Fruttiger M
Exp Eye Res; 2014 Mar; 120():55-60. PubMed ID: 24418725
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-regulated transgene expression in experimental retinal and choroidal neovascularization.
Bainbridge JW; Mistry A; Binley K; De Alwis M; Thrasher AJ; Naylor S; Ali RR
Gene Ther; 2003 Jun; 10(12):1049-54. PubMed ID: 12776163
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization.
Zhang M; Yang Y; Yan M; Zhang J
Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337
[TBL] [Abstract][Full Text] [Related]
13. TMP prevents retinal neovascularization and imparts neuroprotection in an oxygen-induced retinopathy model.
Liang X; Zhou H; Ding Y; Li J; Yang C; Luo Y; Li S; Sun G; Liao X; Min W
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2157-69. PubMed ID: 22410554
[TBL] [Abstract][Full Text] [Related]
14. Adenosine A1 Receptors Selectively Modulate Oxygen-Induced Retinopathy at the Hyperoxic and Hypoxic Phases by Distinct Cellular Mechanisms.
Zhang S; Li H; Li B; Zhong D; Gu X; Tang L; Wang Y; Wang C; Zhou R; Li Y; He Y; Chen M; Huo Y; Liu XL; Chen JF
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8108-19. PubMed ID: 26720463
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-2 Expression During Retinal Vascular Development and Neovascularization.
Fei P; Palenski TL; Wang S; Gurel Z; Hankenson KD; Sorenson CM; Sheibani N
J Ocul Pharmacol Ther; 2015 Sep; 31(7):429-44. PubMed ID: 25950258
[TBL] [Abstract][Full Text] [Related]
16. A Hypoxia-Regulated Retinal Pigment Epithelium-Specific Gene Therapy Vector Reduces Choroidal Neovascularization in a Mouse Model.
Yuan Y; Kong W; Liu XM; Shi GH
Curr Gene Ther; 2022; 22(5):417-426. PubMed ID: 35382718
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary surfactant protein a is expressed in mouse retina by Müller cells and impacts neovascularization in oxygen-induced retinopathy.
Bhatti F; Ball G; Hobbs R; Linens A; Munzar S; Akram R; Barber AJ; Anderson M; Elliott M; Edwards M
Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):232-42. PubMed ID: 25406276
[TBL] [Abstract][Full Text] [Related]
18. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
19. Retinal proteome analysis in a mouse model of oxygen-induced retinopathy.
Kim SJ; Jin J; Kim YJ; Kim Y; Yu HG
J Proteome Res; 2012 Nov; 11(11):5186-203. PubMed ID: 23039900
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy.
DeNiro M; Al-Halafi A; Al-Mohanna FH; Alsmadi O; Al-Mohanna FA
Mol Pharmacol; 2010 Mar; 77(3):348-67. PubMed ID: 20008515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
